Yersinia pestis YadC: A novel vaccine candidate against plague

Advances in Experimental Medicine and Biology

Volumn 603, Issue , 2007, Pages 400-414

  Murphy, Brian S ^a   Straley, Susan C ^a   Garvy, Beth A ^a   Wulf, Christine R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIAL ANTIGEN; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; INTERLEUKIN 12; INTERLEUKIN 6; PLAGUE VACCINE; PROTEIN LCRV; PROTEIN YADC; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VACCINE PRODUCTION; YERSINIA PESTIS;

MUS; YERSINIA PESTIS;

EID: 84934444681     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72124-8_37     Document Type: Conference Paper

References (47)

1. Anderson, G.W., Jr., Worsham, P.L., Bolt, C.R., Andrews, G.P., Welkos, S.L., Friedlander, A.M. and Burans, J.P. (1997). Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg. 56, 571-573.
2. Andrews, G., Heath, D.G., Anderson, Jr., G.W., Welkos, S.L. and Friedlander, A.M. (1996). Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infec. Immun. 64, 2180-2187.
3. Bendtsen, J.D., Nielsen, H., von Heijne, G. and Brunak, S. (2004). Improved detection of signal peptides: SignalP 3.0. J. Mol. Biol. 340: 783-795.
4. Bosio, C., Goodyear, A.W. and Dow, S.W. (2005). Early interaction of Yersinia pestis with APCs in the lung. J. Immunol. 175, 6750-6756.
5. British and US vaccine research groups. (2002). Abstracts O-35 and O-40, 8th International Symposium on Yersinia September 2002. Turky, Finland.
6. Cotter, S., NSurana, N.K. and St. Geme III, J.W. (2005). Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol. 13, 199-205.
7. Cowan C., Philipovskiy, A.V., Wulff-Strobel, C.R., Ye, Z. and Straley, S.C. (2005). Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect. Immun. 73, 6127-6137.
8. Cowan, C., Jones, H.A., Kaya, Y.H., Perry, R.D. and Straley, S.C. (2000). Invasion of epithelial cells by Yersinia pestis: evidence for a Y. pestis-specific invasin. Infect. Immun. 68, 4523-4530.
9. Datsenko, K.A. and Wanner, B.L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. PNAS USA 97, 6640-6645.
10. Davis, K, Fritz, D.L., Pitt, M.L.M., Welkos, S.L., Worsham, P.L. and Friedlander, A.M. (1996). Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch. Pathol. Lab. Med. 120, 156-163.
11. DeBord, K., Anderson, D.M., Marketon, M.M., Overheim, K.A., DePaolo, R.W., Ciletti, N.A., Jabri, B. and Schneewind, O. (2006). Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect. Immun. 74, 4910-4914.
12. Eyles, J., Spiers, I.D., Williamson, E.D. and Alpar, H.O. (1998). Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine 16, 2000-2009.
13. Eyles, J., Elvin, S.J., Westwood, A., LeButt, C.S., Alpar, H.O., Somavarapu, S. and Williamson, E.D. (2004). Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine 22, 4365-4373.
14. Fields, K.A. and Straley, S.C. (1999). LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism. Infect. Immun. 67, 4801-4813.
15. Forman, S., Wulff, C.R., Perry, R.D. and Straley, S.C. (2006). Manuscript in preparation.
16. Friedlander, A., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, Jr., G.W., Pitt, L.M., Estep, J. and Davis, K. (1995). The relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21, S178-S181.
17. Glynn, A., Roy, C.J., Powell, B.S., Adamovicz, J.J., Freytag, L.C. and Clements, J.D. (2005). Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect. Immun. 73, 5256-5261.
18. Glynn, A., Freytag, L.C. and Clements, J.D. (2005). Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23, 1957-1965.
19. Gruchalla, R.S. and Jones, J. (2003). Combating high-priority biological agents: what to do with drug-allergic patients and those for whom vaccination is contraindicated? J. Allergy Clin. Immunol. 112, 675-682.
20. Heath, D., Anderson, Jr., G.W., Mauro, J.M., Welkos, S.L., Andrews, G.P., Adamovicz, J. and Friedlander, A.M. (1998). Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16, 1131-1137.
21. Hoiczyk, E., Roggenkamp, A., Reichenbecher, M., Lupas, A. and Heeseman, J. (2000). Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EBMO J. 19, 5989-5999.
22. Hudson, K., Bliska, J.B. and Bouton, A.H. (2005). Distinct mechanisms of integrin bindings by Yersinia pseudotuberculosis adhesins determine the phagocytic response of host macrophages. Cell. Microbiol. 7, 1471-1489.
23. Inglesby T.V., Dennis, D.T., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Koerner, J.F., Layton, M., McDade, J., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., Schoch-Spana, M. and Tonat, K. (2000). Plague as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. J. Am. Med. Assoc. 283, 2281-2290.
24. Lahteenmaki, K., Kukonen, M. and Korhonen, T.K. (2001). The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells. FEBS Lett. 504, 69-72.
25. Leary, S., Griffin, K.F., Garmory, H.S., Williamson, E.D. and Titball, R.W. (1997). Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 23, 167-179.
26. Marshall J.D., Jr., Bartelloni, P.J., Cavanaugh, D.C., Kadull, P.J. and Meyer, K.F. (1974). Plague immunization. II. relation of adverse clinical reactions to multiple immunizations with killed vaccine. J. Infect Dis. 129(Suppl), S19-S25.
27. Motin, V., Nakajima, R., Smirnov, G.B. and Brubaker, R.R. (1994). Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62, 4192-4201.
28. Nakajima, R., Motin, V.L. and Brubaker, R.R. (1995). Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis of active immunization. Infect. Immun. 63, 3021-3029.
29. Nakajima, R. and Burbaker, R.R. (1993). Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 61, 23-31.
30. Nedialkov, Y., Motin, V.L. and Brubaker, R.R. (1997). Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen- polyhisitidine fusion peptide: amplification of interluekin-10. Infect. Immun. 65, 1196-1203.
31. Nummelin H., Merckel, M.C., Leo, J.C., Lankinen, H., Skurnik, M. and Goldman, A. (2004). The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll. EBMO J 23, 701-711.
32. Perry, R. and Fetherston, J.D. (1997). Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10, 35-66.
33. Philipovskiy, A.V., Cowan, C., Wulff-Strobel, C.R., Burnett, S.H., Kerschen, E.J., Cohen, D.A., Kaplan, A.M. and Straley, S.C. (2005). Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis. Infect. Immun. 83, 1532-1542.
34. Roggenkamp A., Ackerman, N.A., Joacobi, C.A., Truelzsch, K., Hoffman, H. and Heeseman, J. (2003). Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhensin YadA. J. Bacteriol. 185, 3735-3744.
35. Russell, P., Eley, S.M., Hibbs, S.E., Manchee, R.J., Stagg, A.J. and Titball, R.W. (1995). A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13, 1551-1556.
36. Simpson, W., Thomas, R.E. and Schwan, T.G. (1990). Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43, 389-396.
37. Sing, A., Roggenkamp, A., Geiger, A.M. and Heesemann, J. (2002). Yersinia enterocolitica evasion of the host immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168, 1315-1321.
38. Sing, A., Tvardovaskaia, N., Rost, D., Kirschning, C., Wagner, H. and Heesemann, J. (2003). Contribution of Toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int. J. Med. Microbiol. 293, 341-348.
39. Sing, A., Tvardovskaia, N., Rost, D., Kirschning, C.J., Wagner, H. and Heeseman, J. (2003). Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 197, 1017-1024.
40. 2- in Yersinia pestis include structural genes for outer membrane proteins. Infect. Immun. 51, 445-454.
41. Surgalla, M. and Beesley, E.D. (1969). Congo red-agar plating medium for detecting pigmentation in Pasturella pestis. Appl. Microbiol. 18, 834-837.
42. Tahir E.Y. and Skurnik, M. (2001). YadA, the multifaceted Yersinia adhesin. Int. J. Med. Microbiol. 291, 209-218.
43. Welkos, S., Davis, K.M., Pitt, L.M., Worsham, P.L. and Friedlander, A.M. (1995). Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13, 299-305.
44. Williamson, E., Flick-Smith, H.C., LeButt, C., Rowland, C.A., Jones, S.M., Waters, E.L., Gwyther, R.J., Miller, J., Packer, P.J. and Irving, M. (2005). Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 2005, 3598-3608.
45. Williamson, E., Vessey, P.M., Gillhespy, K.J., Eley, S.M., Green, M. and Titball, R.W. (1999). An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116, 107-114.
46. Williamson, E., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (1997). A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15, 1079-1084.
47. Wulff-Strobel, C. R., Williams, A.W. and Straley, S.C. 2001. LcrQ and SycH function together at the Ysc type III secretion system in Yersinia pestis to impose a hierarchy of secretion. Mol. Microbiol. 43, 411-423.